Botox
From Noblood
Contents |
Generic Name
Botulinum toxin Type A
Trade Name
Botox® (USA)
Manufacturer
Description
Purified neurotoxin complex
Blood product ingredient(s)
Human albumin
Percent of Component
0.5 mg
Production
Forms available
Parenteral (local) injection (USA, Canada)
Medicinal Use
Used in treatment of eye conditions such as blepharospasm (eyelid will not stay open due to spasm of eye muscle), strabismus (eyes do not line up properly), muscular conditions such as cervical dystonia (muscle spasms of neck), and hyperhidrosis (severe sweating at armpits).
Risks
Hypersensitivity reaction, anaphylaxis (extremely rare); in patients with known or unknown pre-existing neuromuscular conditions, it is possible to develop severe dysphagia (inability to swallow) or respiratory compromise; since this product contains human albumin, which is a derivative of human blood, there is an extremely remote possibility that viral diseases may be transmitted during administration of Botox® (these include vCJD, or variant Creuzfelt-Jacob Disease). See detailed discussion of risk.
Side Effects
Pain, tenderness and/or bruising at the injection site; weakness of muscles is the intended effect of Botox®, however some weakness of adjacent muscles to the treated area may occur. There have been extremely rare incidence of more serious events, such as myocardial infarction and even death, after administration of this product, but connection of these events to the drug itself is still unknown. See additional details regarding potential and actual side effects.
See also
- Detailed drug information
- Package insert (PDF)
- Allergan.com http://www.allergan.com
- RxList: The Internet Drug Index http://www.rxlist.com/cgi/generic3/botox.htm
NOTICE: The above data is provided by NoBlood as an informational resource only, and should never be used for diagnostic or prescriptive purposes. Always check with your doctor or other qualified medical practitioner before taking any medication. Information presented here was compiled based on the following sources:
